Apollo’s Q4 Profit Up 50% YoY To Rs146 cr, Revenue Climbs 21%

Apollo Hospitals, India’s leading hospital chain clubbed a net profit of Rs 146 crore for the quarter ended March. The profit saw an uptick by 50 per cent from Rs 97 crore posted in same quarter of previous year.

Revenue from operations rose to Rs 4,302 crore in Q4FY23 registering a 21 per cent jump on year as the Q4FY22 revenues stood at Rs 3,546 crore.

EBITDA (earnings before interest, taxes, depreciation, and amortisation) for the company for the quarter was Rs 488 crore, up 5 per cent from Rs 463 crore in Q4FY22.

Margins decreased to 11 per cent in the fourth quarter from 12 per cent in the corresponding period last year. In comparison to Rs 3,344 crore during the same period last year, the company's total expenses increased by 21 per cent during the January-March period.

Revenues from the healthcare services segment climbed 18 per cent to Rs 2,227 crore in the quarter under review. In the same quarter the year before, it totaled Rs 1,879 crore.

Revenues from retail health and diagnostics were Rs 308 crore for the months of January through March, an increase of 4 per cent from Rs 297 crore the previous year.

On the other side, digital health and primary distribution saw revenue increase by 31 per cent YoY to Rs 1,799 crore during Q4 FY23.

Apollo Hospitals reported a profit of Rs 844 crore for the entire year, a decrease of over 24 per cent. In the prior fiscal year, the profit was Rs 1,108 crore.

In comparison to FY22, revenues increased 13 per cent in FY23 to Rs 16,612 crore.

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “The first full post-pandemic year has seen Apollo make some remarkable strides in its journey of healing. Our unwavering commitment to deliver world-class healthcare has enabled us to scale new heights with our performance - both in terms of financial metrics and in the expansion of our healthcare service offerings. We have seen a substantial increase in patient engagement both in our hospitals and clinics, as well as on our digital health platform Apollo 24/7."

The Board has also recommended to the Company's shareholders a final dividend for the FY23 period of Rs 9 per equity share (180 per cent of the face value of Rs 5 per share).

The shareholders' consent at the annual general meeting is required in order for the Board's recommended dividend to be paid. The corporation has set August 19 as the record date to ascertain if stockholders are entitled to the aforementioned dividend payment.

If shareholders at the AGM approve the dividend, it will be paid starting on September 9 and continuing thereafter.